Bioavailability, dosage, and your unique physiology all play a role in timing
Moreover, the magnitude of this effect significantly depended on the dosage: median time to death, or ventilation support, was 570 days for placebo, 1,087 days for 25 mg, and 1,197 days for 50 mg methylcobalamin groups
Eprenetapopt combined with venetoclax and azacitidine in TP53-mutated acute myeloid leukaemia: a phase 1, dose-finding and expansion study
Ferroptosis involves in intestinal epithelial cell death in ulcerative colitis
Dose-response of Paraxanthine on cognitive function: a double blind, placebo controlled, crossover trial
Maternal and child undernutrition: Global and regional exposures and health consequences